Top

Osteoporosis International

Published in:

01-09-2007 | Original Article

Adiponectin is a predictor of bone mineral density in middle-aged premenopausal women

Authors: J. Jürimäe, T. Jürimäe

Published in: Osteoporosis International | Issue 9/2007

Abstract

Summary

Adipose-modulated biochemical signal that explains some of the association between fat mass and bone mineral density (BMD) is adiponectin. The results demonstrated an independent association between adiponectin and BMD, while the influence of adiponectin on bone mineral content is mediated by fat free mass in middle-aged women.

Introduction

Positive association between fat mass (FM) and bone mineral density (BMD) is mediated by biochemical factors.

Methods

The relationship between plasma adiponectin concentration and BMD in 98 sedentary premenopausal women aged 38–49 years with a body mass index range of 20.0–42.1 kg/m² was examined. Different body composition and blood biochemical parameters were measured to adjust for possible confounding variables.

Results

The association between adiponectin and BMD values (total BMD: ß = −0.919; p = 0.0001, femoral neck BMD: ß = −0.925; p = 0.0001 and lumbar spine BMD: ß = −0.912; p = 0.0001) was independent of the influences that measured body composition, hormonal and insulin resistance factors may exert on BMD (p < 0.02). However, adiponectin explained only 3–12% of the variations in measured BMD variables. Similarly, adiponectin was associated with total bone mineral content (BMC; ß = −0.911; p = 0.0001) and remained associated in different analyses that controlled for possible confounding parameters (p < 0.01). However, the association between adiponectin and total BMC was no longer significant when adjusted for fat free mass (FFM; p > 0.21).

Conclusions

Adiponectin is an independent predictor of BMD, while its independent contribution to the interindividual variance in measured values is only modest. The influence of adiponectin on total BMC is mediated or confounded by FFM in middle-aged premenopausal women.

Flegal KM, Carroll MD, Ogden CL, Johnson CL (2002) Prevalence and trends in obesity among US adults, 1999–2000. JAMA 288:1723–1727PubMedCrossRef

Felson DT, Zhang Y, Hannan MT, Anderson JJ (1993) Effects of weight and body mass index on bone mineral density in men and women: the Framingham study. J Bone Miner Res 8:567–573PubMed

Rubin CT, Lanyon LE (1985) Regulation of bone mass by mechanical strain magnitude. Calcif Tissue Int 37:411–417PubMedCrossRef

Lenchik L, Register TC, Hsu FC, Lohman K, Nicklas BJ, Freidman BI, Langefeld CD, Carr JJ, Bowden DW (2003) Adiponectin as a novel determinant of bone mineral density and visceral fat. Bone 33:646–651PubMedCrossRef

Jürimäe T, Jürimäe J, Pihl E (2000) Circulatory response to single circuit weight and walking training sessions of similar energy cost in middle-aged overweight females. Clin Physiol 20:143–149PubMedCrossRef

Jürimäe J, Jürimäe T (2006) Influence of insulin-like growth factor-1 and leptin on bone mineral content in healthy premenopausal women. Exp Biol Med 231:1673–1677

Reid IR (2002) Relationships among body mass, its compartments, and bone. Bone 31:547–555PubMedCrossRef

Abou Samra R, Baba NH, Torbay N, Dib L, El-Hajj Fuleihan G (2005) High plasma leptin is not associated with higher bone mineral density in insulin-resistant premenopausal obese women. J Clin Endocrinol Metab 90:2588–2594PubMedCrossRef

Oh KW, Lee WY, Rhee EJ, Baek KH, Yoon KH, Kang MI, Yun EJ, Park CY, Ihm SH, Choi MG, Yoo HJ, Park SW (2005) The relationship between serum resistin, leptin, adiponectin, ghrelin levels and bone mineral density in middle-aged men. Clin Endocrinol 63:131–138CrossRef

10.

Barrett-Connor E, Kritz-Silverstein D (1996) Does hyperinsulinemia preserve bone? Diabetes Care 19:1388–1392PubMedCrossRef

11.

Ogata N, Chikazu D, Kubota N, Terauchi Y, Tobe K, Azuma Y, Ohta T, Kadowaki T, Nakamura K, Kawaguchi H (2000) Insulin receptor substrate-1 in osteoplast is indispensable for maintaining bone turnover. J Clin Invest 105:935–943PubMedCrossRef

12.

Faraj M, Havel PJ, Phelis S, Blank D, Sneiderman AD, Cianflone K (2003) Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 88:1594–1602PubMedCrossRef

13.

Jürimäe J, Rembel K, Jürimäe T, Rehand M (2005) Adiponectin is associated with bone mineral density in perimenopausal women. Horm Metab Res 37:297–302PubMedCrossRef

14.

Thomas T, Burguera B (2002) Is leptin the link between fat and bone mass? J Bone Miner Res 17:1563–1569PubMedCrossRef

15.

Whipple T, Sharkey N, Demers L, Williams N (2002) Leptin and the skeleton. Clin Endocrinol 57:701–711CrossRef

16.

Kontogianni MD, Dafni UG, Routsias JG, Skopouli FN (2004) Blood leptin and adiponectin as possible mediators of the relation between fat mass and BMD in perimenopausal women. J Bone Miner Res 19:546–554PubMedCrossRef

17.

Zoico E, Zamboni M, Adami S, Vettor R, Mazzali G, Tosoni P, Bissoli L, Bosello O (2003) Relationship between leptin levels and bone mineral density in the elderly. Clin Endocrinol 59:97–103CrossRef

18.

Hadji P, Bock K, Gotschalk M, Hars O, Backhus J, Emons G, Schulz KD (2003) The influence of serum leptin concentration on bone mass assessed by quantitative ultrasonometry in pre and postmenopausal women. Maturitas 44:141–148PubMedCrossRef

19.

Martini G, Valenti R, Giovani S, Franci B, Campagna S, Nuti R (2001) Influence of insulin-like growth factor-1 and leptin on bone mass in healthy postmenopausal women. Bone 28:113–117PubMedCrossRef

20.

Roux C, Arabi A, Porcher R, Garnero P (2003) Serum leptin as a determinant of bone resorption in healthy postmenopausal women. Bone 33:847–852PubMedCrossRef

21.

Scherer PE, Williams S, Fogliano M, Baldini C, Lodish HF (1995) A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270:26746–26749PubMedCrossRef

22.

Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA (2001) Hypoadiponectemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930–1935PubMedCrossRef

23.

Dietz JJ, Iglesias P (2003) The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 148:293–300CrossRef

24.

Matsubara M, Maruoka S, Katayose S (2002) Inverse relationship between plasma adiponectin and leptin concentrations in normalweight and obese women. Eur J Endocrinol 147:173–180PubMedCrossRef

25.

Ryan AS, Berman DM, Nicklas BJ, Sinha M, Gingerich RL, Meneilly GS, Egan JM, Elahi D (2003) Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity. Diabetes Care 26:2383–2388PubMedCrossRef

26.

Bouchard C, Tremblay A, Leblanc C, Lortie G, Savard R, Theriault G (1983) A method to assess energy expenditure in children and adults. Am J Clin Nutr 37:461–467PubMed

27.

Garnett SP, Högler W, Blades B, Baur LA, Peat J, Lee J, Cowell CT (2004) Relation between hormones and body composition, including bone, in prepubertal children. Am J Clin Nutr 80:966–972PubMed

28.

Fernandez-Real JM, Vayreda M, Casamitjana R, Gonzalez-Huix F, Ricart W (2000) The fat-free mass compartment influences serum leptin in men. Eur J Endocrinol 142:25–29PubMedCrossRef

29.

Thong FS, McLean C, Graham TE (2000) Plasma leptin in female athletes: relationship with body fat, reproductive, nutritional, and endocrine factors. J Appl Physiol 88:2037–2044PubMed

30.

Blain H, Vuillemin A, Guillemin F, Durant R, Hanesse B, De Talance N, Doucet B, Jeandel C (2002) Serum leptin level is a predictor of bone mineral density in postmenopausal women. J Clin Endocrinol Metab 87:1030–1035PubMedCrossRef

31.

Yokota T, Meka CS, Medina KL, Igarashi H, Comp PC, Takahashi M, Nishida M, Oritani K, Miyagawa J, Funahashi T, Tomiyama Y, Matsuzawa Y, Kincade PW (2002) Paracrine regulation of fat cell formation in bone marrow cultures via adiponectin and prostaglandins. J Clin Invest 109:1303–1310PubMedCrossRef

32.

Yokota T, Meka CS, Kouro T, Medina KL, Idarashi H, Takahashi M, Oritani K, Funahashi T, Tomiyama Y, Matsuzawa Y, Kincade PW (2003) Adiponectin, a fat cell product, influences the earliest lymphocyte precursors in bone marrow cultures by activation of the cyclooxygenase-prostaglandin pathway in stromal cells. J Immunol 171:5091–5099PubMed

33.

Zhang X, Schwarz EM, Young DA, Puzas JE, Rosier RN, O’Keefe RJ (2002) Cyclooxygenase-2 regulates mesenchymal cell differentiation into osteoblast lineage and is critically involved in bone repair. J Clin Invest 109:1405–1415PubMedCrossRef

34.

Berner HS, Lyngstadaas SP, Spahr A, Monjo M, Thommesen L, Drevon CA, Syversen U, Reseland JE (2004) Adiponectin and its receptors are expressed in bone-forming cells. Bone 35:842–849PubMedCrossRef

35.

Lee WY, Rhee EJ, Oh KW, Kim SY, Jung CH, Yun EJ, Bae KH, Kang MI, Kim SW (2006) Identification of adiponectin and its receptors in human osteoblast-like cells and association of T45G polymorphism in exon 2 of adiponectin gene with lumbar spine bone mineral density in Korean women. Clin Endocrinol 65:631–637CrossRef

36.

Motoshima H, Wu X, Sinha MK, Hardy VE, Rosato EL, Barbot DJ, Rosato FE, Goldstein BJ (2002) Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone. J Clin Endocrinol Metab 87:5662–5667PubMedCrossRef

37.

Chen Z, Lohman TG, Stini WA, Ritenburg C, Aickin M (1997) Fat or lean tissue mass: which one is the major determinant of bone mineral mass in healthy postmenopausal women? J Bone Miner Res 12:144–151PubMedCrossRef

38.

Lindsay R, Cosman F, Herrington BS, Himmelstein S (1992) Bone mass and body composition in normal women. J Bone Miner Res 7:55–63PubMedCrossRef

39.

Reid IR, Ames R, Evans MC, Sharpe S, Gamble G, France JT, Lim TM, Cundy TF (1992) Determinants of total and regional bone mineral density in normal postmenopausal women: a key role for fat mass. J Clin Endocrinol Metab 75:45–51PubMedCrossRef

40.

Salamone LM, Glynn N, Black D, Epstein RS, Palermo L, Meilahn E, Kuller LH, Cauley JA (1995) Body composition and bone mineral density in premenopausal and early perimenopausal women. J Bone Miner Res 12:144–151

41.

Lorentzon M, Landin K, Mellstrom D, Ohlsson C (2006) Leptin is a negative independent predictor of areal BMD and cortical bone size in young adult Swedish men. J Bone Miner Res 21:1871–1878PubMedCrossRef

42.

Kirchengast S, Peterson B, Hauser G, Knogler W (2001) Body composition characteristics are associated with the bone density of the proximal femur end in middle- and old-aged women and men. Maturitas 39:133–145PubMedCrossRef

Title: Adiponectin is a predictor of bone mineral density in middle-aged premenopausal women
Authors: J. Jürimäe
T. Jürimäe
Publication date: 01-09-2007
Publisher: Springer-Verlag
Published in: Osteoporosis International / Issue 9/2007
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-007-0365-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Adiponectin is a predictor of bone mineral density in middle-aged premenopausal women

Abstract

Summary

Introduction

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Summary

Introduction

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 9/2007

Searching for genes underlying susceptibility to osteoporotic fracture: current progress and future prospect

β-blocker use and risk of fractures in men and women from the general population: the MONICA/KORA Augsburg cohort study

Individualization of osteoporosis risk

Effect of seasonality and weather on fracture risk in individuals 65 years and older

Muscle weakness, spasticity and disuse contribute to demineralization and geometric changes in the radius following chronic stroke

Vertebral dimensions as risk factor of vertebral fracture in osteoporotic patients: a systematic literature review